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Self-Reported Sleep Latency in Postmenopausal Women 
The ain of this study was to access how self-reported sleep latency (SRSL) was
affected by sleep habits, mood, and circadian rhythm in postmenopausal women.
Subjects (n=384, 67.9± ±7.7 yr) completed sleep and mood questionnaires, sleep
log and actigraphic data. The major urinary melatonin metabolite (6-sulphatoxyme-
latonin, aMT6s) was assayed in fractional urine specimens for two 24-hr intervals.
Although SRSL (26.5± ±24.4 min) and actigraphic sleep latency (ASL; 27.8± ±20.0
min) were correlated (rs=0.361, p<0.001), the short SRSLs tended to be underesti-
mated whereas the long SRSLs tended to be overestimated as compared to ASL.
SRSL was positively correlated with the scales of insomnia, mood and hot flash,
hypertension, use of anti-hypertensive drugs and the acrophase and the offset of
aMT6s. SRSL was negatively correlated with the global assessment of functioning
scale in DSM-IV (GAF scale), and light exposure and wrist activity. Multiple linear
regression analysis showed that the best-fit model to predict SRSL was light expo-
sure, GAF scale, and use of anti-hypertensive drugs. SRSL may be determined
by psychophysiological factors as well as circadian rhythm function. Therapeutic
approaches suggested for trouble falling asleep might include increased daylight
exposure, improvements in general health, and modification of anti-hypertensive
pharmacotherapy.
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INTRODUCTION
The difficulty in falling asleep is the most classic sleep
complaint, which is often equated with the concept of insom-
nia. Trouble falling asleep is a common complaint heard by
clinicians. Nevertheless, the meaning of this complaint may
be quite variable and complex. It has not been determined
whether a certain sleep latency (time to fall asleep) marks a
threshold between normal and abnormal. 
Self-reported sleep latency (SRSL), the reported time in
falling asleep, may be determined by several biological and
psychosocial factors. Sleep onset time may be influenced by
biological factors determining sleep propensity and by sub-
jective preference or psychosocial factors for determining the
sleep onset time. One hypothesis to describe sleep propensi-
ty is the interaction of homeostatic processes termed ‘process
S’ and circadian process termed ‘process C’ (1). Process S medi-
ates the rise of sleep propensity that increases progressively
during wakefulness or sleep deprivation and decreases pro-
gressively during (non-REM) sleep. Process C represents a
clock-like process underlying a (nearly) 24-hr oscillatory vari-
ation in the propensity of sleep, which is basically indepen-
dent of prior sleep and waking. Thus, sleep propensity asso-
ciated with SRSL can be affected by biological aspects of both
process S and process C. The preferred sleep onset time can
be affected by psychosocial factors such as work, school, exer-
cise, and lifestyle. A longer or shorter SRSL may cause the
discrepancy between the sleep onset time influenced by sleep
biological propensity and the sleep onset time that psychoso-
cial factors might promote. Sleep state misperception such
as overestimation of SRSL compared to objective sleep laten-
cy may affect this discrepancy (2). 
In this study, we focused on SRSL in a large group of post-
menopausal women. The prevalence of insomnia with a
longer SRSL sharply increases in women around the age of
menopause (3-5). In postmenopausal women, complaints of
trouble falling asleep are frequent, although complaints of
mid-sleep awakenings and early awakening are even more
prevalent (6). Specific aims of these analyses were to evalu-
ate how SRSL is affected by sleep habits, mood states, depres-
sive or primary sleep disorders, and circadian phase.1008 D.-H. Park, D.F. Kripke, G. Jean-Louis, et al.
MATERIALS AND METHODS
Subjects
A group of 459 women who had volunteered for the Ob-
servational Study of the Women’s Health Initiative (WHI)
(7) at the San Diego Clinical Center further volunteered for
an ancillary study of sleep. All subjects were relatively healthy
women, living independently in the community. Women
aged 50 to 81 yr with a life expectancy of 3 yr or more were
eligible; subjects were not excluded because of medications
or most illnesses. A group of 384 women who completed at
least 6 days of both of sleep log and actigraphic data were
selected from the larger group for analysis. Other results
from this study have been reported elsewhere (8-11). This
study was approved by the Institutional Review Board of
the University of California San Diego. Each woman gave
written informed consent to participate.
Subjects completed sleep questionnaires, underwent one-
week wrist actigraph recordings at home, and collected frac-
tional urine specimens over two 24-hr intervals. Information
on the body mass index (BMI) and systolic and diastolic blood
pressure was obtained from baseline measurements taken
upon enrollment in the WHI. Blood pressure was calculat-
ed from the mean of two blood pressures in the resting state.
Psychiatric diagnoses were made by a single observer within
1-3 weeks after each subject had completed her wrist acti-
graphic recording.
Questionnaires and psychiatric interview
The WHI insomnia rating scale (12, 13), Burnam mood
screening scale (14), a hot flash rating log (7), a medication
history, and daily sleep logs during actigraphic recording
were completed. The sleep habit questionnaire was composed
of 10 items, and the national distributions of responses to
this questionnaire were described by Kripke et al. (6). Levine
(13) showed that there was a principal insomnia factor in
WHI insomnia rating scale consisting of 5 items of these
10 questionnaire items, which was named by Levine’s fac-
tor. Levine’s factor or insomnia factor was used by the insom-
nia scale in this study. The Burnam mood screening scale
was calculated according to the Burnam-Rand depression P
index (14, 15). The hot flash rating log was the number of
reported total episodes during the actigraphic recording for
7 days. The medication history enumerated analgesics, an-
tacids, anticonvulsants, antidepressants, antihistamines, anti-
hypertensives, antiparkinson pills, bronchodilators, cardiac
drugs (antiarrhythmic drugs), beta blockers or alpha/beta
adrenergic blockers, corticosteroids, cytotoxic drugs, diuret-
ics, hormones, insulin, laxatives, major tranquilizers, minor
tranquilizers, narcotics, over-the-counter hypnotics, oxygen,
sedative hypnotics, stimulants, vasodilating drugs, and other
drugs. During the 1-week home activity recordings, the
women completed a daily sleep log reporting bedtimes, sleep
times, time to fall asleep (SRSL), wake up times, and when
they took the actigraph off the wrist, among other items. A
daily medication history within the sleep log recorded non-
steroidal anti-inflammatory analgesics, estrogen, progestin,
and sleeping pills for each night. This study focused on the
SRSL from these daily sleep logs, specifically the question
‘‘How long did it take you to fall asleep last night?’’ For most
of the items, the women contributed complete data and could
be included in all analyses.
Psychiatric diagnoses including depressive disorders were
done by a board-certified psychiatrist using the Structured
Clinical Interview for DSM-IV Axis I Disorders-Non-patient
Edition (SCID) (16). The global assessment of functioning
scale (GAF scale) of Axis V in SCID evaluated general func-
tioning level; higher values reflected better overall function-
ing. DSM-IV sleep disorder diagnosis was also made, based
on the subjective data, interviews, and actigraphic and oxi-
metry recordings. DSM-IV permitted sleep diagnoses with-
out polysomnography.
Actigraphic data
Wrist activity was recorded with the Actillume I device
(Ambulatory Monitoring, Inc., Ardsley, New York, U.S.A.),
using a precision accelerometer for 7 days (n=363) except
for some subjects measured for 6 days (n=21). The sleep/
wake state of each minute was determined with a computer
algorithm (17). This automatic sleep scoring was edited with
assistance of daily sleep logs, notes, the illumination chan-
nel from the Actillume, and Webster’s rules (18). The acti-
graphic sleep latency (ASL) was the interval from bedtime
to the first minute scored as sleep.
6-Sulfatoxymelatonin (aMT6s) assays
To obtain a marker of circadian system phase, the women
were asked to collect and measure every fractional urine void-
ing volume over two 24-hr intervals in the course of the week,
approximately 3 days apart. They were instructed to urinate
approximately every 2 hr during the day and to collect all
nocturnal voidings, which resulted in an average of 10 sam-
ples per 24 hr. A 2-mL aliquot associated with each collection
interval was frozen at home and then later stored at -70℃
for further assaying in the laboratory. Urinary aMT6s was
assayed by radioimmunoassay (RIA) using melatonin kits
(ALPCO Diagnostics, Windham, HN, U.S.A. with reagents
from Stockgrand LTD) using a 125I-aMT6s tracer (19). At a
sample dilution of 1:125, the sensitivity of the assay was
<0.2 ng/mL. Intra- and inter-assay coefficients of variation
were 3.3% and 6.7%, respectively. When necessary, the sensi-
tivity of this assay was increased further by lessening the
dilution factor. The excretion rate (ng/hr) between voidings
was computed and transformed into 5 min epochs for timeSelf-Reported Sleep Latency in Postmenopausal Women  1009
series display and cosine analysis. Further details of analyz-
ing melatonin data were described in Tuunainen et al. (8).
Subjects with reliable aMT6s (n=332) were selected.
Statistical analysis
Data analyses were performed with SPSS 12.0 statistical
software (SPSS, Inc., Chicago, IL, U.S.A.). Two-sided p<0.05
was regarded as statistically significant. SRSL was transform-
ed by common log transformation to normalize SRSL data.
LT-SRSL (log-transformed SRSL) was used in statistical anal-
yses. The demographic data set included age, BMI, systolic
and diastolic blood pressures, and the use of antihyperten-
sive drug. The behavioral symptom data set was composed
of age, Burnam depressive mood score, GAF scale of DSM-
IV Axis V, and hot flash rating log. The circadian rhythm
data set included daily light exposure and wrist activity, the
acrophases of circadian rhythms such as activity, light, sleep,
and aMT6s, and the onset and offset times of sleep, and aMT6s.
These variables were partially correlated with LT-SRSL con-
trolling age and BMI. Correlations between SRSL and ASL
or difference in SRSL-ASL were used by Spearman correla-
tion because SRSL did not show Gaussian distribution. Mul-
tiple linear regression was used to analyze the relationships
between the dependent variable of LT-SRSL and the inde-
pendent variables of 3-separate variable sets: demographic,
behavioral, and circadian. The non-parametric Kruskal-Wal-
lis test was used to compare four different diagnostic groups
in demographic, questionnaire, sleep and circadian rhythm
data because the number of subject in the current depressive
disorder group (n=10) was too small.
RESULTS
Subject characteristics
The mean age of the 384 women in this sample was 67.9
±7.7 yr. The racial/ethnic distribution of the participants
was 72.7% White, 13.3% Hispanic, 9.1% African-Ameri-
Characteristic Units Mean S.D. Range n
Age Years 67.9 7.7 50-81 384
HFRL Episodes/ 7 days 1.5 6.4 0-90 378
BMI kg/m
2 27.1 6.0 15.6-59.5 284
Systolic BP mmHg 126.3 15.9 90-207 384
Diastolic BP mmHg 74.3 8.6 56-104 384
Table 1. Characteristics of the postmenopausal sample
HFRL, hot flash rating log; BMI, body mass index (weight/height










Onset (hr) 23.51 1.16 22.75 2.05 0.311 <0.001 <0.001
Offset (hr) 6.90 1.06 8.64 1.90 0.387 <0.001 <0.001
Acrophase (hr) 4.92 1.04 3.74 1.85 0.391 <0.001 <0.001
Midpoint (hr) 3.22 1.00 3.68 1.70 0.428 <0.001 <0.001
Onset-to-offset duration (min) 471.5 58.1 588.3 115.9 0.034 0.551 <0.001
Mesor (mm, ng/hr) 0.27 0.04 237.7 271.6 0.096 0.095 -
Amplitude (mm, ng/hr) 0.40 0.06 256.2 379.6 0.175 0.002 -
Table 2. Data of circadian rhythms 
Actigraphic sleep versus aMT6s
ng/h, nanogram/hour; aMT6s, 6-sulphatoxymelatonin. p values of paired sample correlation and t-test were assessed by two-tailed test. The units of











Acrophase (hr) 13.98 1.24 13.76 0.91 0.687  <0.001 <0.001
Mesor (mm, log10lux) 14.38 3.73 1.11 0.26 0.273 <0.001 -
Amplitude (mm, log10lux) 11.70 3.43 1.16 0.62 0.391 <0.001 -
Wrist activity versus light
p values of paired sample correlation and t-test were assessed by two-tailed test. The units of activity and light in mesor and amplitude were indicated
by mm and log10lux, respectively.
Bcan, 4.2% Asian, and 0.8% Native American. Further char-
acteristics of the sample are given in Table 1. Based on pri-
mary insomnia and depressive disorder, 4 groups were select-
ed: 1) primary insomnia without any Axis I disorder (n=20),
2) current depressive disorder with insomnia (n=10), 3) past
depressive disorder without any primary sleep disorder (n=
77), and 4) control (n=140; subjects without any primary
sleep disorder or any past or present Axis I psychiatric disor-
der). The subjects (n=137) who were diagnosed with any
Axis I psychiatric disorder other than primary insomnia or
depressive disorder were excluded in that grouping.
Relationships between sleep and aMT6s circadian rhythms
are shown in Table 2A. The phase timing between the two
rhythms was well-correlated, though not identical, but the
mesor aMT6s and onset-to-offset duration were not related
to sleep duration. The sleep onset-to-offset duration (471.5
±58.1 min) was shorter than the aMT6s (588.3±115.9
min) onset-to-offset duration. Illumination exposure and
activity were correlated in both timing and rhythm ampli-
tude (Table 2B).










SL (min) 26.5 24.4 27.8  20.0 0.387 <0.001 <0.001
Light out time (hr) 23.10 1.09 23.07  1.78 0.947 <0.001 0.083
Sleep onset time (hr) 23.54 1.18 23.53 1.21 0.899 <0.001 <0.001
Light on time (hr) 6.78 1.04 6.92 1.08 0.910 <0.001 <0.001
TIB (min) 460.8 57.0 472.0  59.3 0.882 <0.001 <0.001
SPT (min) 434.4 57.3 444.2  58.2 0.800 <0.001 <0.001
TST (min) - - 360.2  53.9 - - -
TWT (min) - - 111.4  43.8 - - -
WASO (min) - - 86.7  35.5 - - -
Sleep efficiency (%) - - 81.9  7.2 - - -
Sleep percent (%) - - 76.6  8.1 - - -
Daytime nap (min) 17.6 21.6 30.9  32.1 0.611 <0.001 <0.001
Table 3. Self-reported versus actigraphic sleep data
SL, sleep latency; SPT, sleep period time; TIB, time in bed; TST, total sleep time; TWT, total wake time; WASO, wake-up time after sleep onset; Sleep
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Fig. 1. Self-reported sleep latency (SRSL) is correlated with the
difference in SRSL and actigraphic sleep latency (ASL) (SRSL-
ASL) (rs=0.603, p<0.001). Spearman correlation between SRSL
and SRSL-ASL was used because SRSL did not show Gaussian
distribution. The differences between SRSL and ASL tend to be
negative in the short SRSLs whereas positive in the long SRSLs.
As compared to ASL, the short SRSLs tend to be underestimated
whereas the long SRSLs above 50 min tend to be overestimated.
Model Beta SE p value
Demographic data set
Use of antihypertensives 0.206  2.944 0.001 
Age -0.114 0.152 0.069 
Systolic blood pressure 0.035  0.155 0.623 
Body mass index -0.028  0.185 0.638 
Diastolic blood pressure -0.012  0.088 0.874 
Behavioral symptom data set
GAF Scale of DSM-IV Axis V -0.119  0.139 0.044 
Burnam depressive mood score  0.094  8.913 0.110 
Hot flash rating log 0.014  0.162 0.795 
Circadian rhythm data set
Daily light exposure -0.229  5.119 <0.001 
Daily wrist activity Acrophase  -0.080  0.335 0.182 
of aMT6s
Offset time of aMT6s  0.071  0.740 0.301 
Acrophase of light exposure 0.095  2.361 0.350 
Onset time of aMT6s -0.066  0.715 0.354 
Acrophase of wrist activity -0.096  1.796 0.363 
Acrophase of sleep 0.144  4.200 0.502 
Sleep offset time -0.034  2.784 0.813 
Sleep onset time 0.021  2.138 0.860 
Table 4. Multiple linear regression of log-transformed self-report-
ed sleep latency (SRSL) vs. three data sets including possible
factors affecting SRSL
GAF, global assessment of functioning; aMT6s, 6-Sulfatoxymelatonin.Comparison of self-reported vs. actigraphic data
The mean SRSL was 26.5 min (SD 24.4; range, 0.0-161.4).
The mean ASL measured by the Actillume was 27.8 min
(SD 20.0; range 4.7-157.6). SRSL and ASL were correlated
rS=0.387 (p<0.001), but showed a significant mean differ-
ence (Table 3). Self-reported and actigraphic data were more
strongly correlated for other sleep variables than for the sleep
latencies (Table 3). Although SRSL was correlated with the
difference in SRSL and ASL (SRSL-ASL) (rS=0.603, p<0.001),
the differences between SRSL and ASL tend to be negative
in the short SRSLs whereas positive in the long SRSLs (Fig.
1). As compared to ASL, the short SRSLs tended to be under-
estimated whereas the long SRSLs above 50 min tended to
be overestimated (Fig. 1). 
Correlates of SRSL
LT-SRSL did not correlate with the subject’s age or BMI.
In partial correlations controlled for age and BMI, LT-SRSL
was correlated with the insomnia factor (rp=0.331, p<0.001),
the Burnam depression screening scale (rp=0.312, p<0.001),
the hot flash rating log (rp=0.163, p=0.001), and GAF scale
(rp=-0.257, p<0.001). LT-SRSL was significantly associated
with systolic (rp=0.136, p=0.022) and diastolic (rp=0.132, p=
0.027) blood pressures recorded at intake, use of antihyper-
tensive drugs (rp=0.218, p<0.001), beta blockers (rp=0.176,
p=0.004), cardiac drugs (rp=0.132, p=0.031), insulin (rp=
0.168, p=0.006), and diuretics (rp=0.118, p=0.055), but was
not correlated with the uses of sedative and hypnotics, antide-
pressants, anticonvulsants, antihistamines, and minor tran-
quilizers. LT-SRSL was correlated with daily light exposure
(log10 lux) rp=-0.239, p<0.001), daily wrist activity (rp=-0.128,
p=0.028), the acrophase of aMT6s excretion (rp=0.143, p=
0.014) and the offset time of aMT6s excretion (rp=0.204,
p<0.001) in partial correlations controlled for age of circadi-
an rhythm variables.
Factors affecting SRSL
Multiple linear regression analysis showed that the best-
fit model to predict LT-SRSL included the use of antihyper-
tensive drugs (p=0.008) from the demographic data set, GAF
scale of DSM-IV Axis V (p=0.004) from the behavioral symp-


















Self-reported and actigraphic sleep data
SRSL 19.4 16.5 38.2 41.0 34.8 13.1 23.8 17.5 15.462 0.001
ASL 24.1 15.7 27.9 14.3 35.9 16.9 27.4 19.9 9.859 0.020
SR_SPT 437.0 53.5 405.6 54.1 401.7 45.2 443.6 55.1 15.011 0.002
A_SPT 442.5 56.7 445.7 57.0 415.0 62.6 442.3 59.6 2.660 0.447
Circadian rhythm data of acrophases
Sleep 2.79 0.92 2.73 0.84 2.51 1.05 3.00 1.20 3.251 0.354
aMT6s 3.71 1.87 2.95 1.74 3.91 1.75 3.74 2.24 3.500 0.321
Activity 13.77 1.09 13.66 1.21 13.30 1.18 13.94 1.31 2.292 0.514
Light 13.66 0.78 13.70 0.75 13.44 1.48 13.72 0.94 0.056 0.997
Questionnaire data
I-factor 12.1 2.9 15.5 3.9 16.6 4.1 11.6 2.9 26.004 <0.001
Burnam 0.02 0.08 0.03 0.07 0.35 0.33 0.05 0.13 40.108 <0.001
HFRL 0.7 1.9 0.8 1.7 10.1 20.4 0.8 2.7 4.174 0.243
GAF 86.9 6.0 83.5 4.9 67.2 6.1 83.6 7.9 39.169 <0.001
Demographic data
Age 69.4 6.9 68.0 7.7 68.0 7.9 67.9 7.9 1.916 0.590
BMI 26.4 6.4 28.4 8.1 28.7 6.2 26.6 4.7 3.483 0.323
SBP 128.0 16.7 125.2 15.5 137.8 17.1 123.1 14.5 8.680 0.034
DBP 74.3 8.6 76.1 9.0 77.9 10.3 74.3 8.2 1.449 0.694
Table 5. Comparison of control, pure primary insomnia, and depressive disorder without primary sleep disorder in variables related
to SRSL (self-reported sleep latency)
The non-parametric Kruskal-Wallis test was used to compare four different diagnostic groups because the number of subject in current depressive dis-
order group (n=10) was too small.
SRSL, self-reported sleep latency (minutes); ASL, actigraphic sleep latency (minutes); SR_SPT, self-reported sleep period time (minutes); A_SPT, acti-
graphic sleep period time (minutes); SR_Nap, self-reported nap; A_Nap, actigraphic nap; aMT6s, 6-sulphatoxymelatonin; I-factor, insomnia factor
(Levine’s factor selected from WHI insomnia rating scale); Burnam, Burnam-Rand depression P index; HFRL, hot flash rating log (episodes/7days);
GAF, Global Assessment of Functioning scale of Axis V in DSM-IV; BMI, body mass index (weight/height
2); SBP, systolic blood pressure (mmHg);
DBP, diastolic blood pressure (mmHg). Unit of acrophase is hours.toms data set, and daytime light exposure (p=0.023) from
the circadian rhythm data set. In contrast, other variables did
not add significant contributions to the model (Table 4).
Comparison of psychiatric diagnostic groups
The sleep, circadian rhythm, questionnaire, and demogra-
phic data were compured among four different diagnostic
groups (Table 5). In the sleep data, SRSL, ASL and self-re-
ported sleep period time (SPT) showed significant differences,
but actigraphic SPT did not. The circadian rhythm data did
not show any significant differences. The questionnaire data
associated with the insomnia factor (Levine’s factor), Bur-
nam-Rand depression P index, and GAF score showed sig-
nificant differences, but the hot flash rating log did not. In
the demographic data, systolic BP showed a significant dif-
ference, but diastolic BP, age, and BMI did not.
DISCUSSION
The short subjective SRSLs appeared to be underestimated
and the long SRSLs more than 50 min appeared to be over-
estimated as compared with objective ASL (Fig. 1). There is
a well-known tendency to overestimate sleep onset latency
in primary insomnia (20). The discrepancy between SRSL
and ALS in primary insomnia may be due to distorted sleep
perception affected by presleep cognitive and physiological
arousal, as suggested by Tang and Harvey (21). While many
studies about overestimated sleep latency had been done, we
have found no discussion on underestimated sleep latencies
that may be clinically of less concern.
The values of LT-SRSL were significantly associated with
the use of antihypertensive drugs, decreased GAF scale of
DSM-IV Axis V, and decreased daily light exposure in mul-
tiple linear regression analyses intended to emphasize the
major correlates. Possible means to alleviate lengthened SRSL
may include selecting antihypertensive drugs not provoking
insomnia, alleviating impairments caused by mental illnesses
such as the relief of affective illnesses and anxiety disorders,
and promoting increased daily light exposure in underex-
posed subjects.
The current data showed that an increased SRSL was relat-
ed to a mixture of factors, that is, other sleep complaints,
indicators of depression, reported hot flashes, general mea-
sures of activity and global function (inversely), hyperten-
sion, medications such as antihypertensive drugs, and delayed
circadian rhythms in several indices. It has often been report-
ed that depression (as indicated by the Burnam mood screen-
ing scale) was correlated with subjective sleep latency. Depres-
sion was reported as a risk factor associated with insomnia
(22). Chronic insomnia was related to major depression (23).
Hot flashes are one of vasomotor symptoms associated with
insomnia (24). What the GAF scale of Axis V in DSM-IV
accessing psychosocial functioning was inversely correlated
with SRSL suggests that primary insomnia, depressive dis-
order and some other psychiatric disorders decreasing GAF
can be related to the increased SRSL. Unexpectedly, SRSL
was not correlated with the uses of sedative and hypnotics.
It might be inferred that the subjects taking those drugs one
time per week were included in that medicated group or that
SRSL was not likely to be reported short in the group taking
those drugs everyday.
SRSL was inversely correlated with the levels of daily light
exposure and wrist activity, but SRSL was not correlated with
the acrophases of light or activity. One causal pathway might
be that low light exposure leads to depression, which leads
to both lower activity and longer sleep latency. Although
there is a limitation of using self-assessment to measure sleep
and exercise in the methodology, some studies (25) reported
that exercise promoted sleep, as suggested by the reverse
relationship between SRSL and the level of daily activity
presented in the present paper. The review article by Mont-
gomery and Dennis (26) also showed exercise improved sleep
onset latency in elderly individuals. However, Youngstedt
et al. (27) reported that exercise did not promote sleep: an
explanation might be that daytime activity might often be
a proxy for daylight exposure, as in the association of day-
light exposure and daytime activity presented in this paper.
SRSL was correlated with the acrophase and the offset time
of aMT6s, but it was not correlated with the onset time of
aMT6s. This might suggest that delayed circadian rhythms
can prolong sleep latency. It is notable that the offset time of
aMT6s excretion correlated significantly with SRSL instead
of the onset time of aMT6s excretion. This might suggest
that the melatonin offset is the more functionally important
marker to predict SRSL. Unexpectedly, SRSL was not signif-
icantly correlated with the acrophase, onset and offset time
of actigraphic sleep. Perhaps this indicates that the underly-
ing circadian process is more closely anchored in the circa-
dian rhythm of aMT6 less affected by environmental factors
as compared to the circadian rhythm of sleep. 
The sleep, circadian rhythm, questionnaire, and demogra-
phic data were compared among four different diagnostic
groups. SRSL, ASL, self-reported SPT, insomnia factor (Le-
vine’s factor), Burnam-Rand depression P index, GAF score,
and systolic BP showed significant differences. It is of inter-
est that the difference in total sleep time between groups was
greater as reported subjectively than objectively observed.
This may reflect a negative cognitive self-perception of sleep
among depressed and insomniac patients. It was notable that
systolic BP was highest in the current depressive group. Scher-
rer et al. (28) reported that hypertension was significantly
associated with the degree of depression in epidemiological
twin study. However, the present results had a limitation in
that the number of current depressive group was relatively
small as compared with other groups.
The current study had some other limitations. It was based
1012 D.-H. Park, D.F. Kripke, G. Jean-Louis, et al.partly on retrospective data from a study not prospectively
designated to test the hypotheses. Another limitation was
the potential inaccuracy of SRSL by memory bias when the
subjects were asked to estimate SRSR in the next morning.
Another limitation was the modest inaccuracy of the acti-
graphic method for the exact evaluation of sleep data not
supported by nocturnal polysomnography (NPSG). Espe-
cially, ASL may be relatively unreliable actigraphic measure
because some sleepers may lie in bed motionless before they
actually fall asleep. ASL correlated less than other actigraph-
ic measures with self-reported sleep variables as indicated in
Table 3. Another limitation of the study was that the circa-
dian rhythms of aMT6s might be partly masked by room
illumination (29). The association between SRSL and circa-
dian rhythm data, especially the circadian rhythm of mela-
tonin, might be underestimated by the malsynchronization
and the phase dispersion of melatonin circadian rhythm due
to aging (30).
In spite of the limitations aforementioned, this study sug-
gested that SRSL may be determined in a complex manner
by psychophysiological factors as well as circadian rhythm
function. The therapeutic approaches such as increase of day-
light exposure, improvements in general health, or modifica-
tion of anti-hypertensive pharmacotherapy could be suggest-
ed in the long SRSLs that might have trouble falling asleep.
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